Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathoge

LRRK2 · neurodegeneration · -
Composite
0.780
Price
$0.70
Evidence For
0
Evidence Against
0

G2019S basal RAB10 phosphorylation elevation may be secondary; true pathogenic driver is amplified stress-response signaling. Partial LRRK2 inhibition sufficient to normalize stress-induced spikes while preserving necessary baseline functions. LRRK2 knockout mice viability supports non-essential baseline hypothesis. Age-dependent neurodegeneration in knock-in mice suggests stress-dependent pathology rather than chronic baseline elevation.

G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying ly

LRRK2 · neurodegeneration · -
Composite
0.790
Price
$0.79
Evidence For
0
Evidence Against
0

The most supported model is that pathogenic G2019S shifts the basal catalytic set-point upward, producing higher baseline phospho-Rab output while leaving the core lysosomal volume-sensing response architecture largely intact. In this view, mutant cells begin from a higher activity floor, and the key experimental discriminator is whether baseline-normalized EC50, slope, or Emax materially increase during graded swelling.

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

LRRK2LysosomalUnspecified Mechanismneurodegeneration
Convergent signals
  • LRRK2 recurs across 2 selected hypotheses with aligned directionality in lysosomal, unspecified mechanism.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

7/11
dimensions won
Therapeutic Window Exists Because Amplif
7/11
dimensions won
G2019S primarily raises baseline LRRK2 k

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.74
0.86
Evidence
0.78
0.32
Novelty
0.55
0.48
Feasibility
0.88
0.91
Impact
0.92
0.88
Druggability
0.88
0.93
Safety
0.75
0.67
Competition
0.72
0.72
Data
0.82
0.82
Reproducible
0.75
0.80
KG Connect
0.50
0.50

Score Breakdown

DimensionTherapeutic Window Exists BecaG2019S primarily raises baseli
Mechanistic0.7400.860
Evidence0.7800.320
Novelty0.5500.480
Feasibility0.8800.910
Impact0.9200.880
Druggability0.8800.930
Safety0.7500.670
Competition0.7200.720
Data0.8200.820
Reproducible0.7500.800
KG Connect0.5000.500

Evidence

Therapeutic Window Exists Because Amplified Signals (Not Bas

No evidence citations yet

G2019S primarily raises baseline LRRK2 kinase activity rathe

No evidence citations yet

Debate Excerpts

Therapeutic Window Exists Because Amplified Signal

4 rounds · quality: 0.80

Theorist

# Therapeutic/Mechanistic Hypotheses Addressing LRRK2 Signal Amplification vs. Baseline Elevation --- ## Hypothesis 1: G2019S Acts as a Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependen...

Skeptic

# Critical Evaluation of LRRK2 Hypotheses ## Overview The core question—whether G2019S increases signal amplification during lysosomal swelling versus merely elevating the baseline activity floor—re...

Domain Expert

# Feasibility Assessment: LRRK2 G2019S Signal Amplification vs. Baseline Elevation Hypotheses ## Executive Summary The core mechanistic question—whether LRRK2 G2019S drives pathology through amplifi...

Synthesizer

```json { "ranked_hypotheses": [ { "title": "Therapeutic Window Exists Because Amplified Signals (Not Baseline) Drive Pathogenesis (H3)", "description": "G2019S basal RAB10 phosphory...

G2019S primarily raises baseline LRRK2 kinase acti

4 rounds · quality: 0.74

Theorist

1. **Title:** `G2019S raises the LRRK2 kinase floor more than the swelling gain` **Mechanism:** G2019S may primarily increase constitutive catalytic output, producing higher baseline pRab10/pRa...

Skeptic

**Skeptical Read** The main weakness across all six is the same: most cited evidence shows that mutant `LRRK2` can elevate phospho-Rab output or alter lysosomal remodeling, but it does **not** cleanl...

Domain Expert

As of **April 24, 2026**, the hypotheses that most credibly survive are: 1. **#1 Higher baseline kinase activity more than higher swelling gain** 2. **#4 Amplification is context-dependent and strong...

Synthesizer

{ "ranked_hypotheses": [ { "title": "G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain", "description": "The most supported model ...

Price History Overlay